Skip to content
Review Open access

Dioscin in liver diseases: pharmacological mechanisms, translational potential and future perspectives

Aug 2026 · Frontiers in Pharmacology · Vol 17 · 1 citation · 107 references
Medicine

TL;DR

This review systematically summarizes the pharmacological activities, molecular mechanisms, toxicological characteristics, and pharmacokinetic properties of DIO in liver diseases and provides a comprehensive basis for the further development and clinical translation of DIO in the prevention and treatment of liver diseases.

Abstract

Dioscin (C45H72O16, DIO) is a naturally occurring steroidal saponin widely distributed in medicinal plants of the Dioscoreaceae, Liliaceae, and Fabaceae families. Given its remarkable hepatoprotective properties, DIO has attracted increasing attention in recent years. Based on literature retrieved from Web of Science, PubMed, ScienceDirect, and CNKI, this review systematically summarizes the pharmacological activities, molecular mechanisms, toxicological characteristics, and pharmacokinetic properties of DIO in liver diseases. Available evidence demonstrates that DIO exhibits significant therapeutic potential against various liver disorders, including liver injury, metabolic dysfunction-associated steatotic liver disease, cholestatic liver disease, liver fibrosis, and hepatocellular carcinoma. Mechanistically, DIO exerts hepatoprotective effects by regulating oxidative stress, inflammation, lipid metabolism, bile acid homeostasis, apoptosis, autophagy, and ferroptosis through multiple signaling pathways, including Keap1/Nrf2, TGF-β1/Smad, PI3K/Akt/mTOR, Wnt/β-catenin, TLR4/MyD88/NF-κB, and SLC7A11/GPX4. Toxicological studies indicate that DIO is generally well tolerated at therapeutic doses, whereas prolonged exposure or high-dose administration may induce hepatotoxicity, mild hematological toxicity, and gastrointestinal toxicity. Pharmacokinetic investigations reveal that DIO displays slow absorption, extremely low oral bioavailability, and prolonged intestinal retention. After absorption, it is distributed mainly to the liver and lungs, and undergoes deglycosylation, oxidation, and glucuronidation, with fecal excretion serving as the primary elimination route. In addition, this review covers the botanical sources, biological characteristics, novel drug delivery systems, and current research challenges associated with DIO. Overall, it provides a comprehensive basis for the further development and clinical translation of DIO in the prevention and treatment of liver diseases.

Read PDF

Similar papers

Review Aug 2026

Wogonoside: Pharmacology, molecular targets and therapeutic potential.

Current advances in the chemical analysis, pharmacokinetics, biotransformation, molecular pharmacology, and disease-specific actions of wogonoside are summarized, and key challenges for future development are discussed, including variable bioavailability, metabolite contribution, target specificity, pharmacokinetic-pha...

Ming Xie, Jia Liu, Rui-feng Pu et al. · 0 citations
Review Sep 2026

Pharmacological Profile of Thymoquinone: From Cellular Pathways to Nutraceutical Potential.

INTRODUCTION Food-derived biomolecules offer high safety, accessibility, and therapeutic potential. Nigella sativa, particularly its bioactive terpenoid Thymoquinone (TQ), exhibits various pharmacological profile, including antioxidant, anti-inflammatory, and anticancer properties. This review summarizes the mechanisti...

Upagya Gyaneshwari, K. Swati, Anand Prakash et al. · 0 citations
Review Aug 2026

Liquiritigenin: Multifaceted Biological Activities and Mechanistic Insights.

This review comprehensively summarizes the therapeutic potential of LQ and elucidates the molecular mechanisms underlying its principal effects, including hepatoprotective, anticancer, anti-inflammatory, cardioprotective, neuroprotective, and boneprotective activities.

Kai-Yi Lai, Jia-Yu Zhang, Wen-Bo Gao et al. · 0 citations
Review Oct 2026

The Therapeutic Potential of Berberine in Treating Diabetes and Its Complications: Molecular Mechanisms and Future Perspectives.

Diabetes mellitus (DM), a chronic metabolic disorder characterized by persistent hyperglycemia, poses a significant global health burden. Berberine (BBR), a natural isoquinoline alkaloid derived from medicinal plants such as Coptidis Rhizoma, has shown therapeutic promise for DM and its complications. Preclinical and c...

Yi-Le Liao, Yu Gui, Tong-Yi Li et al. · 0 citations
Review Open access Aug 2026

Potential Therapeutic Roles of Icariin in Inflammatory Diseases: From Molecular Mechanisms to Clinical Translation Prospects

Overall, the current evidence indicates broad anti-inflammatory effects of ICA across multiple organ systems, particularly in atherosclerosis and myocardial infarction; however, clinical translation is limited by poor bioavailability and the lack of standardized dosage data.

Сюзмэй Ду, Wei-Feng Li, Mei-Xiu Jiang · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.